Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases

International Archives of Allergy and Immunology
G SteinerJ S Smolen

Abstract

Heterogeneous nuclear ribonucleoprotein (hnRNP) complexes are major constituents of the spliceosome. They are composed of approximately 30 different proteins which can bind to nascent pre-mRNA. Among these, the hnRNP-A/B proteins form a subgroup of highly related proteins: their N-terminal halves consist of two adjacent RNA-binding domains, whereas the C-terminal halves contain almost 50% glycine residues. These proteins represent a group of novel autoantigens which are targeted by autoantibodies from patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and mixed connective tissue disease (MCTD): thus, anti-A2/RA33 autoantibodies target the hnRNP proteins A2, B1, B2 (the 'RA33 complex'), and anti-A1 autoantibodies are directed to the hnRNP proteins A1 and A1b. In SLE, anti-hnRNP-A/B antibodies frequently occur together with antibodies to two other spliceosome-associated antigens, U1 small nuclear RNP (U1-snRNP) and Sm. Epitope-mapping studies have revealed that the major antibody binding sites are located in the RNA-binding regions. Furthermore, there is some indication of disease-specific epitope recognition. Studies in animal models have demonstrated the presence of anti-hnRNP-A/B antibodies in several...Continue Reading

Citations

May 20, 1998·Arthritis and Rheumatism·J S Smolen, G Steiner
Mar 21, 2007·Zeitschrift für Rheumatologie·E FeistG-R Burmester
Jun 2, 2009·Rheumatology·Sergio GeneriniMarco Matucci-Cerinic
May 1, 2001·Journal of Clinical Pathology·E C JuryW J Morrow
Nov 30, 2000·Arthritis Research·P J UtzP Anderson
Dec 30, 2011·The Journal of Investigative Dermatology·Sung Bin ChoDongsik Bang
May 29, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Silvia HayerGeorg Schett
Sep 17, 2014·Archives of Toxicology·See-Wun ChoEun-Young Kim
Jul 24, 2002·Progress in Histochemistry and Cytochemistry·Ann M Dvorak, Ellen S Morgan
Oct 13, 2016·Arthritis Research & Therapy·Stefan VordenbäumenMatthias Schneider
Oct 4, 2007·Annals of the New York Academy of Sciences·Alexander SchaubSylvia Miescher
Jul 5, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ruth FritschGünter Steiner
Nov 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Markus H HoffmannGünter Steiner
Aug 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·H DumortierS Muller
Feb 1, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A M DvorakR P Schleimer
Mar 23, 2021·Autoimmunity Reviews·Nora PetrovskáMária Filková
Apr 29, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Robert W Hoffman, Marcos E Maldonado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.